BGM
IMRX icon

Burkehill Global Management’s Immuneering IMRX Stock Holding History

Burkehill Global Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Hold
300,000
– – 0.08% 140
2025
Q4 		$1.97M Hold
300,000
– – 0.13% 120
2025
Q3 		$2.1M Buy
+300,000
New +$1.56M 0.12% 115

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Burkehill Global Management's IMRX Position: Q1 2026 in Review

Burkehill Global Management held its Immuneering (IMRX) position steady in Q1 2026 at 300,000 shares worth $1.58M. The position accounts for 0.08% of the portfolio, ranked #140.

Burkehill Global Management first reported a position in IMRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.1M in Q3 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Burkehill Global Management held 300,000 shares of Immuneering worth $1.58M as of Q1 2026.
  • Burkehill Global Management left its Immuneering share count unchanged in Q1 2026.
  • Immuneering made up 0.08% of Burkehill Global Management's portfolio in Q1 2026, its #140 holding.
  • Burkehill Global Management first reported a position in Immuneering in Q3 2025 and has held it in 3 quarters since.
  • Burkehill Global Management's Immuneering position peaked at $2.1M in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.